Text Size

Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Yufeng Li, Ph.D., University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT01004562
First received: October 29, 2009
Last updated: November 14, 2012
Last verified: November 2012
History of Changes
  Purpose

RATIONALE: Collecting and storing information from patients with cancer to study in the future may help doctors learn more about cancer.

PURPOSE: This study is collecting information from patients enrolled in the Breast Specialized Program of Research Excellence.


Condition Intervention
Breast Cancer
 Other: informational intervention

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: The Breast Cancer Specialized Program of Research Excellence (SPORE): Core A-Administrative/Biostatistics Core

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Alabama at Birmingham:

Primary Outcome Measures:
  • Administrative and biostatistical support for the Breast Specialized Program of Research Excellence [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Enrollment: 1025
Study Start Date: August 2007
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • Provide a database for administrative and biostatistical support for the Breast Specialized Program of Research Excellence.

OUTLINE: Data is collected from patients for future research studies.

PROJECTED ACCRUAL: A total of 535 patients will be accrued for this study.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Breast cancer patients of any age

Criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of breast cancer

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01004562

Locations
United States, Alabama
UAB Comprehensive Cancer Center
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators
University of Alabama at Birmingham
National Cancer Institute (NCI)
Investigators
Principal Investigator: Yufeng Li, PhD University of Alabama at Birmingham
  More Information

Additional Information:
Clinical trial summary from the National Cancer Institute's PDQ® database  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Yufeng Li, Ph.D., Associate Professor, University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT01004562     History of Changes
Other Study ID Numbers: CDR0000378061, UAB-X010112005
Study First Received: October 29, 2009
Last Updated: November 14, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:
breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on May 21, 2013